Each year, it has actually been reported that approximately 1.7 million Americans are diagnosed with cancer (American Cancer Society, 2025). For a number of them, radiation treatment, an exactly calibrated beam of ionizing energy targeted at damaging malignant cells while sparing the healthy tissues surrounding them, will be the gold requirement for their treatment. The word “specifically” does the heavy lifting in this context due to the fact that, in many cases, what separates an alleviative dosage from the one that damages the cells might be a little portion of a millimeter or some mathematical presumptions embedded deep inside a medical facility’s treatment preparation software application.
Emmanuel Bankole wishes to ensure those presumptions are right.
A medical and health physicist currently based in Arkansas, Bankole has actually devoted his career to the science of radiation security and dosimetry, the discipline of determining and modeling how radiation moves through the body and the developed environment. His work mostly sits out of public view, stashed in the quality assurance laboratories of cancer centers and imaging facilities. However the concerns he is pursuing have implications for patients, healthcare employees, and the wider infrastructure of radiation medication throughout the United States.
Questioning a Fundamental Assumption
Bankole’s a lot of consequential research study difficulty concerns a statistical presumption that has actually long been baked into radiotherapy simulations: the uncertainty in the dose provided to non-target tissues follows a regular, or bell-curve, distribution. This might sound technical. However, its effects deeply impact human beings.
Treatment preparation systems (TPS) use likelihood designs to anticipate exactly how much a growth will be irradiated, and, accidentally, Organs At Danger (OAR) such as the liver, spinal column, and heart. If these designs are built on a problematic distributional presumption, there is a high probability that clinicians using them may systematically undervalue the risk of damage to healthy tissues in some clients and overestimate it in others; neither result is sensible or appropriate.
“If the distribution we’re assuming doesn’t reflect what’s really occurring in the simulation, then the unpredictability bounds we report aren’t informing the whole fact,” Bankole describes. “And in radiation treatment, the entire reality is what keeps patients safe,” he asserts even more.
On the other hand, his master’s degree job at Rensselaer Polytechnic Institute, finished in December 2024, directly addressed this question, examining whether the normal distribution presumption holds up under scrutiny for non-target dose uncertainty in radiotherapy simulations. The findings demonstrate potential ramifications not only for specific treatment strategies however also for the computational requirements that countless centers throughout the country rely on.
Constructing the Shield
Parallel to his dosimetry research, Bankole has actually spent years examining the physical structures developed to protect ionizing radiation. His graduate thesis at the University of Lagos focused on Monte Carlo simulation, a powerful computational strategy that models the probabilistic behavior of radiation particles as they pass through matter, to evaluate the efficiency of various protecting materials for a Cobalt-60 radiotherapy system.
Cobalt-60 machines stay in prevalent use for cancer treatment worldwide (Ramanathan, V. (2021 ). Getting the shielding right in the bunkers that house the makers is not simply a theoretical workout, however a regulative and ethical commitment of every facility that runs one. Bankole’s simulation work contributed directly to the science of how to do it better.
“Monte Carlo lets you ask ‘what if’ questions that you simply can not ask or test-run in a real scientific environment,” Bankole says. “You can test fifty various protecting configurations on a computer before a single wall is ever developed. That’s tremendously important for center designers, for regulators, and ultimately for individuals who work in those spaces every day,” he verifies even more.
From the Laboratory to the Center
Bankole’s work is not confined to simulation. Since March 2024, he has actually been used as a Medical and Health Physicist at West Physics, among the leading medical physics seeking advice from firms in the United States. In that role, he carries out hands-on compliance testing and security assessments for diagnostic imaging equipment: X-ray systems, CT scanners, MRI machines, Mammography systems, Nuclear Medicine cams, at health centers and imaging centers across the area.
The work is governed by a thicket of federal and state guidelines, which are imposed by bodies such as the Nuclear Regulatory Commission, the Food and Drug Administration, the American College of Radiology, and the Joint Commission. Every tool Bankole examines must meet rigorous performance standards before it is medically used on a patient. His task is to make sure such contact, and in fact, any drawbacks coming from it, are documented with clinical accuracy.
This is, in numerous ways, the useful application of whatever he has studied. “You learn the theory in graduate school, however the real education is comprehending how that theory interacts with the intricacies of a genuine medical facility environment,” he states. Discussing further, Bankole notes that “While every facility is a little different and every device has its own quirks, the objective is always the very same: to protect the patient, protect the personnel, and make the science operate in the real life.”
A National Difficulty, a National Chance
The United States operates thousands of managed radiation centers, medical facilities, cancer treatment centers, and imaging clinics under a patchwork of federal and state oversight structures. The standards governing how those centers are designed, run, and examined circulation from a reasonably little neighborhood of researchers, clinical physicists, and regulators whose released work and professional agreement shape practice nationwide.
Bankole intends to end up being a significant voice in that community. His near-term objectives consist of pursuing board certification through the American Board of Radiology (ABR), presenting research study documents at conferences arranged by the American Association of Physicists in Medication (AAPM) and the Health Physics Society, and contributing to the task groups and working groups that develop the dosimetry and quality control requirements the entire field trusts.
The United States deals with documented workforce challenges in medical physics, driven by retirements and a minimal training pipeline. These shortages are especially pronounced in rural and underserved areas, where recruiting certified medical physicists can take years and may restrict access to sophisticated radiation oncology services. As a result, each newly trained medical physicist represents an essential addition to the nationwide labor force (Kramer, D. 2023).
“This field requires individuals who comprehend both the computational aspect and the medical side,” Bankole says. He then declares, “I want to be someone who can move in between those worlds and help bridge the gap.”
A Path Constructed Throughout 2 Continents
Bankole’s qualifications consist of 2 graduate degrees, experience throughout two continents, and over a years of progressively sophisticated competence. He finished in the top one percent of his undergraduate physics class at Ekiti State University in Nigeria before making a Master of Science in Medical Physics from the University of Lagos, where his Monte Carlo shielding research first developed his reputation as a competent computational physicist. He then crossed the Atlantic to finish a Master of Engineering in Nuclear Engineering at Rensselaer Polytechnic Institute, one of the oldest and most prestigious technical universities in the United States.
Along the way, he has actually co-authored 3 peer-reviewed publications in 2025 alone, consisting of one in Catalysis Science & Innovation, published by the Royal Society of Chemistry. He holds certifications from the International Atomic Energy Firm in radiation security and a 6 Sigma Green Belt in health care, along with professional subscriptions in both the American Association of Physicists in Medicine (AAPM), the Health Physics Society (HPS), and the American Physical Society (APS).
For a field that depends on the mindful build-up of proficiency and the sluggish, methodical enhancement of scientific standards, Bankole’s profile is exactly what the discipline needs: a researcher happy to question fundamental assumptions, a clinician who has worked inside the facilities where those assumptions play out, and an expert devoted to translating both into better results for clients throughout the nation.
The beam used to treat cancer is undetectable. So is the majority of the work that makes it safe. Emmanuel Bankole is great with that. The results are what matter.